A randomized phase III trial of myeloablative autologous peripheral blood stem cell (PBSC) transplant (ASCT) for high-risk neuroblastoma (HR-NB) employing immunomagnetic purged (P) versus unpurged (UP) PBSC: A Children’s Oncology Group study

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Kreissman, SG; Villablanca, JG; Seeger, RC; Grupp, SA; London, WB; Maris, JM; Park, JR; Cohn, SL; Matthay, KK; Reynolds, CP

Published Date

  • May 20, 2008

Published In

Volume / Issue

  • 26 / 15_suppl

Start / End Page

  • 10011 - 10011

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2008.26.15_suppl.10011

Language

  • en